v3 Template
C

Circular Genomics, Inc.

Healthcare / Biotechnology ~40 employees
Founded
--
Employees (Est.)
~40
4 leaders known
Total Funding
$23.6M
Funding Rounds
3
Last Funding
2025-12-01

About Circular Genomics, Inc.

Circular Genomics is a company focused on advancing precision medicine through a novel circular RNA approach to improve the diagnosis and treatment of psychiatric and neurological disorders. They aim to enhance the treatment journey for patients with mental health disorders by leveraging precision medicine and circular RNA biomarkers.

Products & Services

MindLight:The first antidepressant response test using brain-derived biomarkers, designed to predict if a patient with Major Depressive Disorder (MDD) will respond to SSRI antidepressant treatment, aiming to streamline the treatment selection process.
MindLight™

Specialties

Precision Medicine Circular RNA Biomarkers Psychiatric and Neurological Disorders Mental Health Diagnostics circular RNA biomarkers neurological disorders diagnostics psychiatric disorders diagnostics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 15000000
MR: -
FA: $15 million
FAN: 15000000 		D: 2025-12-01
FD: 2025-12-01 		4 investors
2 RT: Investment
T: -
FT: Investment 		A: 250000
MR: -
FA: $250,000
FAN: 250000 		D: 2025-07-08
FD: 2025-07-08 		1 investors
3 RT: Series A
T: -
FT: Series A 		A: 8300000
MR: -
FA: $8.3 Million
FAN: 8300000 		D: 2024-01-24
FD: 2024-01-24 		5 investors
Series A Latest
2025-12-01
$15.0M
4 investors (Pro only)
Investment 2025-07-08
$250K
Series A 2024-01-24
$8.3M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Paul Sargeant

President and Chief Executive Officer, Member of Board of Directors

N

Nikolaos Mellios

Chief Scientific Officer, Member of Board of Directors, Cofounder

S

Sami Shihabi

Chief Commercial Officer

G

Greg Decker

Chief Financial Officer

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Circular Genomics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~40 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro